- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 8 x IMP: INOSINIC ACID(Covalent)
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
GTP.2: 14 residues within 4Å:- Chain A: K.114, Q.117, I.120, P.123, F.144, C.145, G.146, S.164, S.165, K.213, A.228, T.230, D.231
- Ligands: ATP.4
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:Q.117, A:Q.117, A:C.145, A:G.146, A:G.146, A:S.164, A:S.165, A:T.230, A:T.230
- Salt bridges: A:K.213, A:K.213, A:K.213
GTP.3: 9 residues within 4Å:- Chain A: E.116, L.199, K.200, N.203, D.231, L.232, N.235, K.243, K.247
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:E.116, A:N.203, A:N.203, A:N.235, A:K.243
- Salt bridges: A:D.231, A:K.247, A:K.247
GTP.6: 14 residues within 4Å:- Chain B: K.114, Q.117, I.120, P.123, F.144, C.145, G.146, S.164, S.165, K.213, A.228, T.230, D.231
- Ligands: ATP.8
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:Q.117, B:Q.117, B:C.145, B:G.146, B:G.146, B:S.164, B:S.165, B:T.230, B:T.230
- Salt bridges: B:K.213, B:K.213, B:K.213
GTP.7: 9 residues within 4Å:- Chain B: E.116, L.199, K.200, N.203, D.231, L.232, N.235, K.243, K.247
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:E.116, B:N.203, B:N.203, B:N.235, B:K.243
- Salt bridges: B:D.231, B:K.247, B:K.247
GTP.10: 14 residues within 4Å:- Chain C: K.114, Q.117, I.120, P.123, F.144, C.145, G.146, S.164, S.165, K.213, A.228, T.230, D.231
- Ligands: ATP.12
12 PLIP interactions:12 interactions with chain C- Hydrogen bonds: C:Q.117, C:Q.117, C:C.145, C:G.146, C:G.146, C:S.164, C:S.165, C:T.230, C:T.230
- Salt bridges: C:K.213, C:K.213, C:K.213
GTP.11: 9 residues within 4Å:- Chain C: E.116, L.199, K.200, N.203, D.231, L.232, N.235, K.243, K.247
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:E.116, C:N.203, C:N.203, C:N.235, C:K.243
- Salt bridges: C:D.231, C:K.247, C:K.247
GTP.14: 14 residues within 4Å:- Chain D: K.114, Q.117, I.120, P.123, F.144, C.145, G.146, S.164, S.165, K.213, A.228, T.230, D.231
- Ligands: ATP.16
12 PLIP interactions:12 interactions with chain D- Hydrogen bonds: D:Q.117, D:Q.117, D:C.145, D:G.146, D:G.146, D:S.164, D:S.165, D:T.230, D:T.230
- Salt bridges: D:K.213, D:K.213, D:K.213
GTP.15: 9 residues within 4Å:- Chain D: E.116, L.199, K.200, N.203, D.231, L.232, N.235, K.243, K.247
8 PLIP interactions:8 interactions with chain D- Hydrogen bonds: D:E.116, D:N.203, D:N.203, D:N.235, D:K.243
- Salt bridges: D:D.231, D:K.247, D:K.247
GTP.18: 14 residues within 4Å:- Chain E: K.114, Q.117, I.120, P.123, F.144, C.145, G.146, S.164, S.165, K.213, A.228, T.230, D.231
- Ligands: ATP.20
12 PLIP interactions:12 interactions with chain E- Hydrogen bonds: E:Q.117, E:Q.117, E:C.145, E:G.146, E:G.146, E:S.164, E:S.165, E:T.230, E:T.230
- Salt bridges: E:K.213, E:K.213, E:K.213
GTP.19: 9 residues within 4Å:- Chain E: E.116, L.199, K.200, N.203, D.231, L.232, N.235, K.243, K.247
7 PLIP interactions:7 interactions with chain E- Hydrogen bonds: E:N.203, E:N.203, E:N.235, E:K.243
- Salt bridges: E:D.231, E:K.247, E:K.247
GTP.22: 14 residues within 4Å:- Chain F: K.114, Q.117, I.120, P.123, F.144, C.145, G.146, S.164, S.165, K.213, A.228, T.230, D.231
- Ligands: ATP.24
12 PLIP interactions:12 interactions with chain F- Hydrogen bonds: F:Q.117, F:Q.117, F:C.145, F:G.146, F:G.146, F:S.164, F:S.165, F:T.230, F:T.230
- Salt bridges: F:K.213, F:K.213, F:K.213
GTP.23: 9 residues within 4Å:- Chain F: E.116, L.199, K.200, N.203, D.231, L.232, N.235, K.243, K.247
7 PLIP interactions:7 interactions with chain F- Hydrogen bonds: F:N.203, F:N.203, F:N.235, F:K.243
- Salt bridges: F:D.231, F:K.247, F:K.247
GTP.26: 14 residues within 4Å:- Chain G: K.114, Q.117, I.120, P.123, F.144, C.145, G.146, S.164, S.165, K.213, A.228, T.230, D.231
- Ligands: ATP.28
12 PLIP interactions:12 interactions with chain G- Hydrogen bonds: G:Q.117, G:Q.117, G:C.145, G:G.146, G:G.146, G:S.164, G:S.165, G:T.230, G:T.230
- Salt bridges: G:K.213, G:K.213, G:K.213
GTP.27: 9 residues within 4Å:- Chain G: E.116, L.199, K.200, N.203, D.231, L.232, N.235, K.243, K.247
7 PLIP interactions:7 interactions with chain G- Hydrogen bonds: G:N.203, G:N.203, G:N.235, G:K.243
- Salt bridges: G:D.231, G:K.247, G:K.247
GTP.30: 14 residues within 4Å:- Chain H: K.114, Q.117, I.120, P.123, F.144, C.145, G.146, S.164, S.165, K.213, A.228, T.230, D.231
- Ligands: ATP.32
12 PLIP interactions:12 interactions with chain H- Hydrogen bonds: H:Q.117, H:Q.117, H:C.145, H:G.146, H:G.146, H:S.164, H:S.165, H:T.230, H:T.230
- Salt bridges: H:K.213, H:K.213, H:K.213
GTP.31: 9 residues within 4Å:- Chain H: E.116, L.199, K.200, N.203, D.231, L.232, N.235, K.243, K.247
7 PLIP interactions:7 interactions with chain H- Hydrogen bonds: H:N.203, H:N.203, H:N.235, H:K.243
- Salt bridges: H:D.231, H:K.247, H:K.247
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.4: 15 residues within 4Å:- Chain A: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Chain F: R.166
- Ligands: GTP.2
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain F- Hydrogen bonds: A:S.164, A:S.165, A:S.165, A:R.166, A:D.167, A:V.191, A:V.191, A:K.213
- Salt bridges: A:R.166, A:R.166, A:K.213, F:R.166
ATP.8: 15 residues within 4Å:- Chain B: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Chain E: R.166
- Ligands: GTP.6
12 PLIP interactions:11 interactions with chain B, 1 interactions with chain E- Hydrogen bonds: B:S.164, B:S.165, B:S.165, B:R.166, B:D.167, B:V.191, B:V.191, B:K.213
- Salt bridges: B:R.166, B:R.166, B:K.213, E:R.166
ATP.12: 15 residues within 4Å:- Chain C: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Chain H: R.166
- Ligands: GTP.10
12 PLIP interactions:11 interactions with chain C, 1 interactions with chain H- Hydrogen bonds: C:S.164, C:S.165, C:S.165, C:R.166, C:D.167, C:V.191, C:V.191, C:K.213
- Salt bridges: C:R.166, C:R.166, C:K.213, H:R.166
ATP.16: 15 residues within 4Å:- Chain D: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Chain G: R.166
- Ligands: GTP.14
12 PLIP interactions:11 interactions with chain D, 1 interactions with chain G- Hydrogen bonds: D:S.164, D:S.165, D:S.165, D:R.166, D:D.167, D:V.191, D:V.191, D:K.213
- Salt bridges: D:R.166, D:R.166, D:K.213, G:R.166
ATP.20: 15 residues within 4Å:- Chain B: R.166
- Chain E: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Ligands: GTP.18
13 PLIP interactions:12 interactions with chain E, 1 interactions with chain B- Hydrogen bonds: E:S.164, E:S.165, E:S.165, E:R.166, E:D.167, E:T.185, E:V.191, E:V.191, E:K.213
- Salt bridges: E:R.166, E:R.166, E:K.213, B:R.166
ATP.24: 15 residues within 4Å:- Chain A: R.166
- Chain F: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Ligands: GTP.22
13 PLIP interactions:12 interactions with chain F, 1 interactions with chain A- Hydrogen bonds: F:S.164, F:S.165, F:S.165, F:R.166, F:D.167, F:T.185, F:V.191, F:V.191, F:K.213
- Salt bridges: F:R.166, F:R.166, F:K.213, A:R.166
ATP.28: 15 residues within 4Å:- Chain D: R.166
- Chain G: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Ligands: GTP.26
13 PLIP interactions:12 interactions with chain G, 1 interactions with chain D- Hydrogen bonds: G:S.164, G:S.165, G:S.165, G:R.166, G:D.167, G:T.185, G:V.191, G:V.191, G:K.213
- Salt bridges: G:R.166, G:R.166, G:K.213, D:R.166
ATP.32: 15 residues within 4Å:- Chain C: R.166
- Chain H: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Ligands: GTP.30
13 PLIP interactions:12 interactions with chain H, 1 interactions with chain C- Hydrogen bonds: H:S.164, H:S.165, H:S.165, H:R.166, H:D.167, H:T.185, H:V.191, H:V.191, H:K.213
- Salt bridges: H:R.166, H:R.166, H:K.213, C:R.166
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
P
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 8 x IMP: INOSINIC ACID(Covalent)
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
P